Why is race and diversity important in clinical trials?

Race and diversity in clinical trials are crucial because they ensure that research findings are applicable to the broader population, reflecting variations in genetics, Biology, and responses to treatments across different demographic groups. Diverse participation helps identify potential disparities in health outcomes and treatment efficacy, ultimately leading to more equitable healthcare solutions. Additionally, including varied populations can enhance the generalizability of clinical trial results, fostering trust and improving recruitment in future studies.